The role of the CD40 pathway in the pathogenesis and treatment of cancer

Current Opinion in Pharmacology
Aristides G Eliopoulos, Lawrence Young

Abstract

CD40 is a tumour necrosis factor receptor family member that is overexpressed in a broad range of leukaemias, lymphomas and carcinomas, and could contribute to their development. Recent experimental and clinical observations suggest that the CD40 pathway can be exploited for the treatment of malignancy. The mechanisms by which CD40 activation exerts anti-tumour effects include inhibition of tumour cell proliferation, sensitisation to other anti-cancer agents, including cytotoxic drugs, upregulation of immune processing and presentation within the malignant cells, and stimulation of anti-tumour immune responses via activation of dendritic cells. Thus, the CD40 pathway provides an opportunity to muster different anti-cancer approaches in one therapy, and offers an attractive option for future clinical trials.

Citations

Aug 21, 2012·Cancer Immunology, Immunotherapy : CII·Geneviève DumasCarlos Reyes-Moreno
Apr 2, 2013·Cancer Immunology, Immunotherapy : CII·Ann L WhiteMartin J Glennie
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·T WethalS D Fosså
Jul 31, 2013·Immunology Letters·Bikui ZhangRen Guo
Aug 11, 2005·Oncogene·Amanda J BaxendaleAristides G Eliopoulos
May 21, 2008·The Journal of Experimental Medicine·Cornelia Hömig-HölzelUrsula Zimber-Strobl
Nov 2, 2005·Molecular and Cellular Biology·Clare C DaviesAristides G Eliopoulos
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert H Vonderheide, Martin J Glennie
Aug 9, 2005·Leukemia & Lymphoma·Tom Geldart, Tim Illidge
Aug 5, 2011·Immunobiology·Malek JundiWalid Mourad
Mar 16, 2016·Nature Reviews. Clinical Oncology·Danny N KhalilJedd D Wolchok
Feb 11, 2015·Medical Oncology·Jing GuoKai-Xi Fan
Jan 13, 2015·Current Opinion in Immunology·Cariad ChesterHolbrook E Kohrt
May 21, 2013·Journal of the American Academy of Dermatology·Georgia LevidouPenelope Korkolopoulou
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert H VonderheideScott J Antonia
Mar 23, 2017·Pharmacology & Therapeutics·Jason Lohmueller, Olivera J Finn
May 21, 2005·Nature Reviews. Cancer·Dan Laheru, Elizabeth M Jaffee
Aug 13, 2013·The Journal of International Medical Research·Zhi-Qing WangQin Shi
Jul 12, 2013·Clinical Medicine Insights. Oncology·April K S Salama
Jun 16, 2018·Nature Reviews. Drug Discovery·Patrick A MayesAxel Hoos
Feb 14, 2018·The Journal of Experimental Medicine·Sabine HovesCarola H Ries
May 31, 2007·International Journal of Cancer. Journal International Du Cancer·Nikolaos T GeorgopoulosLudwik K Trejdosiewicz
Feb 7, 2008·European Journal of Immunology·Torry A Tucker, Lisa M Schwiebert
Jun 5, 2010·Neurochemical Research·Gisela IrmischJoerg Richter
Jan 22, 2019·International Journal of Cancer. Journal International Du Cancer·Sandra M M IrenaeusGustav J Ullenhag
Oct 30, 2008·Journal of Immunotoxicology·Daniel J BaltrukonisLynne Lesauteur
Dec 12, 2007·FEMS Microbiology Letters·Dale R WaltersSimon J P Oxley
Aug 8, 2017·Current Medicinal Chemistry·Bin LiPingping Chen
Jul 12, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ann L WhiteMartin J Glennie
Dec 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Taha ElmetwaliDaniel H Palmer
Jan 17, 2020·Scientific Reports·Taha ElmetwaliDaniel H Palmer
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ignacio MeleroPaolo A Ascierto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2022 Meta ULC. All rights reserved